Regenerative medicines are headed for people with Parkinson’s disease or severe heart failure — but researchers are concerned about minimal clinical-trial data.

Age-related memory decline and neurodegenerative diseases like Alzheimer's are often thought of as irreversible. But the brain is not static; neurons continually adjust the strength of their ...

Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

For the first time ever, an anti-aging drug is providing hope for millions who suffer from this common condition.

The CL1 is the first commercial system from the same researchers who wowed the tech world in 2022 by teaching a cluster of ...

In a wild experiment, it turns out a few human neurons linked up to some custom silicon can actually play Doom.

A pioneering clinical trial is exploring whether lab-engineered stem cells can restore dopamine production in people with Parkinson’s disease.

China has stunned the global medical community with a revolutionary cure for Type 2 diabetes, offering hope to millions ...

A groundbreaking clinical trial is testing whether specially engineered stem cells can help the brain restore its own dopamine production in people with Parkinson’s disease. Because the condition is ...

In our cells, our DNA carries chemical or 'epigenetic' marks that decide how genes will be used in different tissues. Yet in the group of specialised ...